MarketsandMarkets Next-Gen Digital Pathology Conference

WHAT TO EXPECT

Innovative research in digital pathology
Understanding and integrating computational pathology & Cloud computing
Critical role of digital pathology and AI in clinical decision making
Examining the latest developments in imaging technologies
Application of digital pathology in drug discovery
Standardisation methods & guidelines- Quality assurance, control, and improvement
Machine learning and AI models for improved prediction performance
Overcoming challenges in image analysis
Use of digital pathology in artificial intelligence for prediction and for better patient identification for appropriate treatment

Participate in discussions with experts on how technology implementation can be improved
Recognize what digital pathology is and how it can be used in the practice of pathology
Attracting and retaining world-class pharma and biotech talent
Improve the efficiency of bio-manufacturing by engaging in environmentally sustainable methods
Discuss the challenges associated with interfacing a digital pathology system
Discover the latest technology implementations in the industry
Discover best-in-class solutions during the workshop sessions
Interactive panel discussions

Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist, Presidents, Vice Presidents, Directors, Heads, Managers,

Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors

Hospital Designations - Senior scientist, scientist, pathologist

Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Lab technicians

Hospitals - Department of Pathology Informatics and Digital Pathology. Department of Haematology, Department of Diagnostics Pathology, Department of Chemical pathology

CONFERENCE AGENDA

Registration (Morning Refreshments and Networking)	08:30 - 09:10
Welcome note from MarketsandMarkets	09:10 - 09:15
Opening Remarks from the Chairperson Lewis Hassell, Professor of Pathology, University of Oklahoma Health Sciences	09:15 - 09:30
DIGITAL PATHOLOGY – STRATEGY, CHALLENGES AND SCOPE
Identification and validation of a pro-fibrogenic macrophage population using cyclic immunofluorescence imaging Shoh Asano, Principal Scientist Microscopy and Image Analysis, Pfizer	09:30 - 10:00
HCR™ Imaging: Modern tools built for mission-critical workflows Dr. Aneesh Acharya, Vice President of Commercial, Molecular Instruments, Inc	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Pathology Training Everywhere and Anywhere: How Digital Pathology and AI Change our Training Paradigm Lewis Hassell, Professor of Pathology, University of Oklahoma Health Sciences	11:15 - 11:45
The role of structured data in digital pathology today and tomorrow Colin Murphy, CEO, mTuitive	11:45 - 12:15
Digital Pathology and Lab Medicine Esther Abels, Past President/Founder, Digital Pathology Association/SolarisRTC LLC	12:15 - 12:45
Over 2 Million Digital Diagnoses Leveraging Technology Built for the Entire Pathology Ecosystem James Thackeray, Chief Commercial Officer , Lumea Matthew O. Leavitt, Founder /Executive Director, Lumea/DDx Foundation	12:45 - 13:30
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:30 - 14:30
AI AND DIGITAL IMAGE ANALYSIS
Advanced Digital Pathology: Whole Tissue Imaging- Whole Block Imaging-Whole Slide Imaging Yukako Yagi, Director of Pathology Digital Imaging, Department of Pathology, Memorial Sloan Kettering Cancer Center	14:30 - 15:00
Advances in machine learning to improve domain generalizability of digital pathology algorithms Ylaine Gerardin, Principal Biomedical Data Scientist, PathAI	15:00 - 15:30
Whole-slide digital image analysis-based quantification of picrosirius red stain variability in formalin-fixed, paraffin embedded liver sections – implications for collagen assessment Yutian Zhan, Principal Scientist, Pfizer	15:30 - 16:00
Evening Refreshments and Poster Presentation \| One-to-One Networking Meetings	16:00 - 16:45
Panel Discussion Session – Implementation of Whole Slide Imaging for Clinical Purposes: Issues to Consider Yukako Yagi, Director of Pathology Digital Imaging, Department of Pathology, Memorial Sloan Kettering Cancer Center Hongbo Yu, MD, PhD, Chief, Pathology and Laboratory Medicine Service, Director, Boston Area Consolidated Laboratories, VA Boston Healthcare System Ylaine Gerardin, Principal Biomedical Data Scientist, PathAI Terry Melim, Sr. Scientist II, Abbvie	16:45 - 17:15
Closing Remarks from the Chairperson Yukako Yagi, Director of Pathology Digital Imaging, Department of Pathology, Memorial Sloan Kettering Cancer Center	17:15 - 17:15
Drinks Reception & Networking	17:15 - 17:15
End of Day 1	17:15 - 17:15

Registration (Morning Refreshments and Networking)	08:30 - 09:10
Welcome note from MarketsandMarkets	09:10 - 09:15
Opening Remarks from the Chairperson Zhenzi Yu, Data Scientist, Drug Product and Device Development, Takeda	09:15 - 09:30
COMPUTATIONAL PATHOLOGY AND ROLE OF PHARMA IN DIGITAL PATHOLOGY
Understanding and integrating computational pathology & cloud computing Alina Ainbinder, Principal Research Scientist, Experimental & Molecular Pathology, Takeda Pharmaceuticals	09:30 - 10:00
Computational Pathology: The next revolution in cancer diagnostics Mark Gustavson, Senior Director, Head Computational Pathology Translational Science, AstraZeneca	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
AI/ML Enabled Precision Pathology in Drug Development Qing Li, Director of Clinical Pathology, Moderna	11:15 - 11:45
Panel Discussion - How much is enough: The challenge to create high-quality AI training data Qing Li, Director of Clinical Pathology, Moderna Alina Ainbinder, Principal Research Scientist, Experimental & Molecular Pathology, Takeda Pharmaceuticals Zhenzi Yu, Data Scientist, Drug Product and Device Development, Takeda Terry Melim, Sr. Scientist II, Abbvie	11:45 - 12:15
Advantages of a Large-Scale Clinical Workflow Together with a Pharma Research Data Repository Sunil Singhal, Chief of Digital Pathology Transformation, Baylor College of Medicine	12:15 - 12:45
HER2 Grading of Breast Cancer using WSI: From Molecular to Morphology Analysis Hossain Md Shakhawat, Assistant Professor of Computer Science and Engineering Department, IUB	12:45 - 13:15
Closing Remarks from the Chairperson Zhenzi Yu, Data Scientist, Drug Product and Device Development, Takeda	13:15 - 13:20
Lunch \| One-to-One Networking Meetings	13:20 - 13:20
End of the conference	13:20 - 13:20